Increased risk of brain metastases in patients with HER‐2/<i>neu</i>‐positive breast carcinoma

Abstract

Data from previous studies have indicated that overexpression of HER‐2/ neu appears to be correlated with more aggressive disease, increased metastatic potential, and poorer prognosis in patients with breast carcinoma.